Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Emergent Biosolutions Inc (EBS)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Emergent Biosolutions's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
1.86 -0.04    -2.11%
18/04 - Closed. Currency in USD ( Disclaimer )
Pre Market
1.85
-0.01
-0.54%
5:07:30 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 779,612
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 1.83 - 1.99
Emergent Biosolutions 1.86 -0.04 -2.11%

NYSE:EBS Financials

 
A brief overview of the NYSE:EBS financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Emergent Biosolutions over time.

Emergent BioSolutions Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 5.7 million compared to USD 4.9 million a year ago. Revenue was USD 1,049.3 million compared to USD 1,117.5 million a year ago. Net loss was USD 760.5 million compared to USD 211.6 million a year ago. Basic loss per share from continuing operations was USD 14.85 compared to USD 4.22 a year ago. Diluted loss per share from continuing operations was USD 14.85 compared to USD 4.22 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

EBS Income Statement

Gross margin TTM 23.08%
Operating margin TTM -18.28%
Net Profit margin TTM -72.48%
Return on Investment TTM -6.89%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 276.6 270.5 337.1 165.1
Gross Profit 55.2 90.4 123.7 -27.1
Operating Income -50.7 -11.9 15.4 -144.6
Net Income -49.5 -263.4 -264.6 -183

EBS Balance Sheet

Quick Ratio MRQ 0.46
Current Ratio MRQ 1.04
LT Debt to Equity MRQ 68.77%
Total Debt to Equity MRQ 135.15%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 1823.2 1893.1 2178.8 2949.8
Total Liabilities 1173.9 1195.9 1222.5 1747.2
Total Equity 649.3 697.2 956.3 1202.6

EBS Cash Flow Statement

Cash Flow/Share TTM -3.98
Revenue/Share TTM 20.22
Operating Cash Flow  4.93%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 32.1 60 -114.4 -184
Cash From Investing Activities -11.4 -18.9 257.7 -15.1
Cash From Financing Activities 4.7 -43 -486.9 -10.5
Net Change in Cash 23.9 -0.8 -341.6 -212.4
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

EBS Comments

Write your thoughts about Emergent Biosolutions Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
david Griffith
david Griffith Sep 08, 2023 2:19PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Did you realize the sale and closing of the sale yielded sbstantial funds and along with management plans to reduce expenses $100MM and other decisions, the September (this month) debt refincing date which caused the going concern 10k warning to now is pushed out into 2025. Thus the conditions for the perfect short of a bebt laden company with a near term refinancing date deadline whe interest rates shot up in less than a year.....have changed mateeresting rt position remaining, what if they (like in the mme stocks) had a catalyst causing short covering to occur? Pleas permit me a fantasy in that case. Neverthe less, the changes seem to create a new season perhaps for stockholders...new and old. Interesting would you think?
Reply
1 0
Report
david Griffith
david Griffith Sep 08, 2023 2:19PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What could 5+ X normal avg. daily volume today (8/15/23 mean? Someone giving up hope for EBS.....Someone else covering a very successful short position Which is the best decision?
Reply
0 0
Report
Astyanaks King
Astyanaks King Sep 08, 2023 2:19PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
how do you see it now? I was expecting 3,67 but it going deeper.
Reply
0 0
Report
Luka Tsirekidze
Luka Tsirekidze Aug 01, 2023 12:05PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
big comeback is coming earning will be awesome maybe to this mont end price is 21$🚀🤑🤑🤑
Reply
3 1
Report
Vlas Dacian
Vlas Dacian Mar 22, 2023 6:42PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Adding just around 5$
Reply
0 1
Report
Ajay Mayor
Ajay Mayor Feb 24, 2023 1:03PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Solid projections possible with OTC Narcan
Reply
0 0
Report
Istvan Szilasi
Istvan Szilasi Feb 09, 2023 2:32PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I see a comeback to 23ish in this stock, but a 12 too, which i think/hope will be soon. Then I jump in. Wish me luck.
Reply
0 0
Report
Avi Surana
Avi Surana Jun 27, 2022 9:28AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
https://www.aviseanalytics.com/heres-why-emergent-biosolutions-is-worth-investing/
Reply
1 0
Report
Le Mt
Le Mt Nov 11, 2021 5:31AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Bottom line is 25. GL
Reply
0 1
Report
Blloc Blloc
Blloc Blloc Nov 05, 2021 12:22PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I think It will recover 20%+ EOD
Reply
1 0
Report
James Bo
James Bo Nov 05, 2021 12:04PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Well, I think it’s bottomed at 30.7 Jumping in
Reply
3 0
Report
Alexander Eryzalim
Alexander Eryzalim Jun 27, 2021 2:19PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
🚀
Reply
3 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email